Download PDF
Homœopathic Links 2023; 36(03): 191-198
DOI: 10.1055/s-0043-1770386
Review Article

A Systematic Review of Homoeopathic Research on Gout and Hyperuricaemia: Road Ahead

Pooja Gautam 
1   Regional Research Institute for Homoeopathy, Guwahati, Assam under Central Council for Research in Homoeopathy, India
,
Meetu Goel 
2   Dr. D.P. Rastogi Central Research Institute of Homoeopathy, under Central Council for Research in Homoeopathy, Noida, Uttar Pradesh, India
,
Amulya Ratna Sahoo 
1   Regional Research Institute for Homoeopathy, Guwahati, Assam under Central Council for Research in Homoeopathy, India
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Objective This study aimed to systematically review the literature on homeopathic researches on gout and hyperuricaemia.

Materials and Methods A comprehensive online and manual search for research studies on the efficacy of homeopathy in gout and/or hyperuricaemia in clinical trials, in vitro and in vivo experimentation was conducted. All types of studies related to the homeopathic treatment of gout and hyperuricaemia in a human trial, animal experimentations and in vitro experiments on hyperuricaemia, published from January 2001 to January 2022 were considered for review. The methodology was assessed by Jadad scoring for clinical trials, the internal validity of randomised controlled trials by the Cochrane collaboration tool, model validity by Mathie's criteria and the internal validity of observational studies and case reports by the Joanna Briggs Institute (JBI) criteria and JBI appraisal checklist, respectively.

Results A total of 16 articles related to homoeopathy on hyperuricaemia and gout were identified, including one preliminary qualitative study, six clinical observational studies, two double-blind, randomised placebo-controlled trials, three case reports, and four animal experiments including one in vitro trial also. Methodological quality analysed by Jaded scoring was diverse, ranging from 0 to 4; by the Cochrane collaboration tool, out of two randomised controlled trials, one had a high risk of bias, while the other had a low risk of bias; observational out of seven studies, only two had a ‘low' risk of bias, three had a ‘moderate' risk and two had a ‘high' risk of bias; JBI appraisal checklist for case report showed two had a ‘low' & one had a ‘moderate' risk of bias.

Conclusion This review demonstrates the effectiveness of homoeopathy in all clinical studies, case reports and in vivo and in vitro models studied under the review, but it is difficult to reach a definite conclusion due to a small number of good quality clinical trials, randomised trials and of laboratory experiments.

Keywords

gout - hyperuricaemia - homoeopathy - observational studies - randomised control trial

Supplementary Material



Publication History

Article published online:
07 August 2023

© 2023. Thieme. All rights reserved.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Raja S, Kumar A, Aahooja RD, Thakuria U, Ochani S, Shaukat F. Frequency of hyperuricemia and its risk factors in the adult population. Cureus 2019; 11 (03) e4198 DOI: 10.7759/cureus.4198.
    CrossrefPubMedGoogle Scholar
  • 2 Engel B, Just J, Bleckwenn M, Weckbecker K. Treatment options for gout. Dtsch Arztebl Int 2017; 114 (13) 215-222
    PubMedGoogle Scholar
  • 3 Gautam P, Goel M, Sahoo AR. Homeopathy for gout and/or hyperuricemia: protocol for a systematic review. Int J AYUSH 2022; 11 (06) 143-152
    PubMedGoogle Scholar
  • 4 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535 DOI: 10.1136/bmj.b2535.
    CrossrefPubMedGoogle Scholar
  • 5 Liberati A, Altman DG, Tetzlaff J. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700 DOI: 10.1136/bmj.b2700.
    CrossrefPubMedGoogle Scholar
  • 6 Beller EM, Glasziou PP, Altman DG. et al; PRISMA for Abstracts Group. PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med 2013; 10 (04) e1001419 DOI: 10.1371/journal.pmed.1001419.
    CrossrefPubMedGoogle Scholar
  • 7 Kumar N. (2022). Gout & Its Homoeopathic Approach. International Journal of Advanced Ayurveda, Yoga, Unani, Siddha and Homeopathy, 11(1), pp. 669–673. Accessed May 26, 2023 at: https://cloudjl.com/index.php/Ayurveda/article/view/42
    PubMed
  • 8 Sharma P, Singh P, Bhinda A. Hyperuricemia: a systemic review. World J Pharm Res 2021; 10 (01) 911-922
    PubMedGoogle Scholar
  • 9 Katoch T, Vangani AK. Primary gout and its homoeopathic approach. Tantia University J Homoeopath Med Sci 2019; 2 (03) 46-49
    PubMedGoogle Scholar
  • 10 Pathak D, Gautam K. A Review on: Current approaches on Gout. Research & Reviews. J Med 2018; 8 (01) 18-22
    PubMedGoogle Scholar
  • 11 Schmidt RA. A Case of Gout - Comparison Between Colchicum, Ledum, And Benzoic Acid. The Hahnemannian Gleanings Vol. 25. Dr. D.S. Bhar Hahnemann Publishing Co. Pvt. Ltd. Pg 76–79
    PubMed
  • 12 Patel S, Biswas B, Rambabu K. et al. Pharmacognostic and physicochemical study of Urtica urens L.: a drug used in homoeopathy. Indian J Res Homoeopathy 2019; 13: 91-99
    CrossrefPubMedGoogle Scholar
  • 13 Singh B, Gupta J, Mohan R, Gupta R, Pal K. Hypouricemic significance of Ledum Palustre (Marsh Tea): a review. Research J Pharm and Tech 2021; 14 (05) 2907-2912
    CrossrefPubMedGoogle Scholar
  • 14 Jadad AR, Moore RA, Carroll D. et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996; 17 (01) 1-12
    CrossrefPubMedGoogle Scholar
  • 15 Higgins JP, Altman DG, Gøtzsche PC. et al; Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928
    CrossrefPubMedGoogle Scholar
  • 16 Mathie RT, Van Wassenhoven M, Jacobs J. et al. Model validity of randomised placebo-controlled trials of individualised homeopathic treatment. Homeopathy 2015; 104 (03) 164-169
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Moola S, Munn Z, Tufanaru C. et al. Joanna Briggs Institute Reviewer's Manual. Australia: The Joanna Briggs Institute; 2017: 5
    Google Scholar
  • 18 Cara R, Tikly M, Solomon EM, Deroukakis M. Homeopathic treatment of acute Gout. Am J Homeopath Med 2007; 100: 40-44
    PubMedGoogle Scholar
  • 19 Nayak C, Pattanaik N, Chattopadhyay A. et al. Individualized homeopathic medicines and Urtica urens mother tincture in treatment of hyperuricemia: an open, randomized, pragmatic, pilot trial. J Complement Integr Med 2020; 18 (03) 599-608
    CrossrefPubMedGoogle Scholar
  • 20 Ahmad M, Faraazi AA, Aamir MN. The effect of Ocimum sanctum and Ledum palustre on serum uric acid level in patients suffering from gouty arthritis and hyperuricemia. Bull Chem Soc Ethiop 2013; 27: 469-473
    PubMedGoogle Scholar
  • 21 Saha S, Sarkar P, Chattopadhyay R, Saha S. An open-label prospective observational trial for assessing the effect of homeopathic medicines in patients suffering from gout. Indian J Res Homoeopathy 2019; 13: 236-243
    CrossrefPubMedGoogle Scholar
  • 22 Deep A, Kumar A. Homoeopathic management of hyperuricemia in primary gout: a randomized, single-blind placebo-controlled study. Int J Homoeopath Sci 2020; 4 (01) 73-77
    CrossrefPubMedGoogle Scholar
  • 23 Prasad AB. A clinical study to evaluate the effectiveness of Urtica urens in the treatment of Gout by analyzing serum uric acid levels. (STSH190118). M.G.R. Medical University; 2019. . Available at: http://103.78.239.181:9090/jspui/bitstream/123456789/3094/1/Arya.B.Prasad.pdf
    Google Scholar
  • 24 Biswas B, Mandal S. Role of individualized homoeopathic medicine in the treatment of gout - an observational study. J Intgr Stand Homoeopathy 2021; 4: 75-79
    CrossrefPubMedGoogle Scholar
  • 25 Sahani A, Banerjee A, Kumar A, Kumari S. Individualized homeopathy as an adjunct in the treatment of gout – a randomized placebo-controlled trial. Allg Hom Ztg. 2017; 262: R07-R03
    PubMedGoogle Scholar
  • 26 Smulders H. The homeopathic simillimum treatment of acute arthritis in primary Gout in terms of the illness intrusiveness scale, blood uric acid levels using the uricase conversion method, as well as the acupulse homeostat machine. DUT Open Scholar Faculty Health Sci 2001 DOI: 10.51415/10321/2069
    CrossrefPubMedGoogle Scholar
  • 27 Bala R, Shrivastava A. Case report on hyperuricemia presenting as a one-sided disease. Homœopathic Links 2019; 32 (02) 105-111
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Gautam P. A case report of hyperuricemia with nephrolithiasis treated with homeopathy. Indian J Res Homoeopathy. 2021; 15: 147-154
    CrossrefPubMedGoogle Scholar
  • 29 Rajan SS, Shibina K. A case of gout treated with homoeopathic constitutional remedy. Int J Homoeopath Scis 2020; 4 (03) 365-368
    CrossrefPubMedGoogle Scholar
  • 30 Shaukat A, Hussain K, Bukhari NI, Shehzadi N. Acid Uric 3 tablet: standardization and pharmacological evidence of uric acid use as anti-gout medicine. J Pharm Pharmacogn Res 2020; 8 (06) 501-514
    PubMedGoogle Scholar
  • 31 Shaffique S, Ahmed S, Rehman T. et al. Anti-hyperuricemic potential of Rhododendron tomentosum Harmaja syn. Ledum palustre L. 30c and 1M in potassium oxonate induced rat model. Indian J Tradit Knowl 2018; 17 (04) 724-731
    PubMedGoogle Scholar
  • 32 Shafique S, Ahmed S, Rehman T. et al. Antihyperuricemic activity of gum of Calophyllum inophyllum ultra high dilutions in potassium oxonate induced Wister albino rats. Indian J Tradit Knowl 2019; 18 (02) 356-359
    PubMedGoogle Scholar
  • 33 Yashwanth BM, Rai SS, Gowda KPS. Effect of Bryonia alba homeopathic formulation in monosodium urate induced gouty arthritis and potassium oxonate induced Hyperuricemia in experimental animals. World J Pharm Pharm Sci 2015; 4 (01) 1120-1134
    PubMedGoogle Scholar